Kalaris Therapeutics, Inc.
KLRS
$3.54
$0.164.73%
NASDAQ
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -10.20M | -3.41M | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | 186.00K | 793.00K | |||
| Total Other Non-Cash Items | 223.00K | 169.00K | |||
| Change in Net Operating Assets | 2.35M | -2.08M | |||
| Cash from Operations | -7.44M | -4.52M | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | 7.50M | 4.99M | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | 1.59M | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 99.77M | -5.00K | |||
| Cash from Financing | 107.27M | 6.58M | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 99.83M | 2.06M | |||